Mohammad O Hussaini (Mohammad Hussaini)

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 6

Top Topics

Allogeneic Hematopoietic Stem Cell Transplantation

Acute Myeloid Leukemia

Tyrosine Kinase

Top Venues

American journal of hematology

Journal of clinical pathology

European journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Parth C Patel, Somedeb Ball, Akriti Gupta Jain, Chen Wang, Mohammad O Hussaini, Luis E Aguirre, Onyee Chan, Seongseok Yun, Andrew T Kuykendall, Eric Padron, Kendra L Sweet, Jeffrey E Lancet, Rami S Komrokji, David A Sallman
Drivers of deep molecular response and long-term outcomes in patients with core binding factor acute myeloid leukemia. American journal of hematology (2023)
Christopher B Ryder, Hayder Saeed, Mohammad O Hussaini
Composite Lymphoma with Follicular Lymphoma Transformation to Clonally Related Epstein-Barr Virus (EBV) Positive Diffuse Large B-Cell Lymphoma and EBV-PositiveClassic Hodgkin Lymphoma. Case reports in hematology 2023 (2023)
Marah Hennawi, Nagehan Pakasticali, Hammad Tashkandi, Mohammad O Hussaini
Genomic Landscape of Mixed-Phenotype Acute Leukemia. International journal of molecular sciences 23 (19) (2022)
Ratilal Akabari, Dahui Qin, Mohammad O Hussaini
Technological Advances: CEBPA and FLT3 Internal Tandem Duplication Mutations Can be Reliably Detected by Next Generation Sequencing. Genes 13 (4) (2022)
Amy Song, Omar Altabbakh, David A Sallman, Eric Padron, Chetasi Talati, Mohammad O Hussaini
Acquisition of IDH2 mutations in relapsed/refractory AML is associated with worse patient outcomes. European journal of haematology 107 (6) (2021)
Ibraahim Badaat, Sabbir Mirza, Eric Padron, David Sallman, Rami Komrokji, Jinming Song, Mohammad O Hussaini
Concurrent mutations in other epigenetic modulators portend better prognosis in BCOR-mutated myelodysplastic syndrome. Journal of clinical pathology 73 (4) (2019)